Skip to main content
Erschienen in: Supportive Care in Cancer 2/2016

01.02.2016 | Review Article

Non-pharmacological cancer pain interventions in populations with social disparities: a systematic review and meta-analysis

verfasst von: Anna Santos Salas, Jorge Fuentes Contreras, Susan Armijo-Olivo, Humam Saltaji, Sharon Watanabe, Thane Chambers, Lori Walter, Greta G. Cummings

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Global advances in pain relief have improved the quality of life of cancer populations. Yet, variation in cancer pain outcomes has been found in populations with social disparities compared to mainstream groups. Populations with social disparities bear an inequitable distribution of resources such as ethnic minorities, low income individuals, and women in vulnerable circumstances.

Research purpose

A systematic review and meta-analysis of the effect of non-pharmacological cancer pain interventions in cancer populations with social disparities of income, ethnicity, or gender.

Methods

Randomized controlled trials, controlled trials, and before and after studies were targeted through comprehensive multidatabase searches. Two reviewers independently screened titles/abstracts for potentially relevant studies and reviewed the full text of relevant articles for inclusion. Data were extracted from included studies by one reviewer and verified by another reviewer. Four reviewers independently completed quality assessment. Studies were grouped by intervention. Effects were evaluated for heterogeneity and pooled.

Results

The search found 5219 potential records. Full text of 26 reports was evaluated. Three randomized controlled trials (RCTs) met inclusion criteria, targeting ethnic minorities and underserved populations and/or women. Interventions included education, coaching, and online support groups. Studies found no significant differences in pain reduction between intervention and control groups or between ethnic minorities and their counterparts. A high risk of bias was found in all studies. Meta-analysis found no statistically significant difference on pain intensity among underserved groups, ethnic minorities, or between ethnic minorities and white counterparts.

Conclusion

Results show the need to examine supportive care interventions particularly in populations with social disparities.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
First Nations are one of the three Indigenous cultural groups in Canada as recognized by the Canadian Constitution Act.
 
Literatur
2.
Zurück zum Zitat Loppie Reading C, Wien F (2009) Health inequalities and social determinants of Aboriginal Peoples’ health. National Collaborating Centre for Aboriginal Health, Prince George, B.C Loppie Reading C, Wien F (2009) Health inequalities and social determinants of Aboriginal Peoples’ health. National Collaborating Centre for Aboriginal Health, Prince George, B.C
4.
5.
Zurück zum Zitat Beiser M, Stewart M (2005) Reducing health disparities: a priority for Canada. Can J Public Health 96(Suppl 2):S4–S7 Beiser M, Stewart M (2005) Reducing health disparities: a priority for Canada. Can J Public Health 96(Suppl 2):S4–S7
6.
Zurück zum Zitat Whitehead M, Dahlgren G (2006) Levelling up (part 1): a discussion paper on concepts and principles for tackling social inequities in health. Studies Social Econ Determinants Population Health 2 Whitehead M, Dahlgren G (2006) Levelling up (part 1): a discussion paper on concepts and principles for tackling social inequities in health. Studies Social Econ Determinants Population Health 2
7.
Zurück zum Zitat WHO Commission on Social Determinants of Health, World Health Organization (2008) Closing the gap in a generation: health equity through action on the social determinants of health. World Health Organization, Commission on Social Determinants of Health, Geneva WHO Commission on Social Determinants of Health, World Health Organization (2008) Closing the gap in a generation: health equity through action on the social determinants of health. World Health Organization, Commission on Social Determinants of Health, Geneva
8.
Zurück zum Zitat Reutter L, Kushner KE (2010) Health equity through action on the social determinants of health’: taking up the challenge in nursing. Nurs Inq 17(3):269–280PubMedCrossRef Reutter L, Kushner KE (2010) Health equity through action on the social determinants of health’: taking up the challenge in nursing. Nurs Inq 17(3):269–280PubMedCrossRef
9.
Zurück zum Zitat King M, Smith A, Gracey M (2009) Indigenous health part 2: the underlying causes of the health gap. Lancet 374(9683):76–85PubMedCrossRef King M, Smith A, Gracey M (2009) Indigenous health part 2: the underlying causes of the health gap. Lancet 374(9683):76–85PubMedCrossRef
10.
Zurück zum Zitat Raphael D (2006) Social determinants of health: present status, unanswered questions, and future directions. Int J Health Serv 36(4):651–677PubMedCrossRef Raphael D (2006) Social determinants of health: present status, unanswered questions, and future directions. Int J Health Serv 36(4):651–677PubMedCrossRef
11.
Zurück zum Zitat Raphael D (2009) Poverty, human development, and health in Canada: research, practice, and advocacy dilemmas. Can J Nurs Res 41(2):7–18PubMed Raphael D (2009) Poverty, human development, and health in Canada: research, practice, and advocacy dilemmas. Can J Nurs Res 41(2):7–18PubMed
14.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90PubMedCrossRef
15.
Zurück zum Zitat Veenstra G (2011) Race, gender, class, and sexual orientation: intersecting axes of inequality and self-rated health in Canada. Int J Equity Health 10(1):1–11CrossRef Veenstra G (2011) Race, gender, class, and sexual orientation: intersecting axes of inequality and self-rated health in Canada. Int J Equity Health 10(1):1–11CrossRef
16.
Zurück zum Zitat George U, Ramkissoon S (1998) Race, gender, and class: interlocking oppressions in the lives of south Asian women in Canada. Affilia 13(1):102–119CrossRef George U, Ramkissoon S (1998) Race, gender, and class: interlocking oppressions in the lives of south Asian women in Canada. Affilia 13(1):102–119CrossRef
17.
Zurück zum Zitat Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14):2137–2150PubMedCrossRef Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14):2137–2150PubMedCrossRef
19.
Zurück zum Zitat Canadian Partnership Against Cancer (2014) Examining disparities in cancer control: a system performance special focus report. Toronto, ON Canadian Partnership Against Cancer (2014) Examining disparities in cancer control: a system performance special focus report. Toronto, ON
21.
Zurück zum Zitat Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef
22.
Zurück zum Zitat Health Canada (2013) First nations health status report - Alberta region: 2011-2012. Health Canada, Ottawa Health Canada (2013) First nations health status report - Alberta region: 2011-2012. Health Canada, Ottawa
23.
Zurück zum Zitat International Atomic Energy Agency (2011) Inequity in cancer care: a global perspective. IAEA Human Health Reports, vol 3. Vienna, Austria International Atomic Energy Agency (2011) Inequity in cancer care: a global perspective. IAEA Human Health Reports, vol 3. Vienna, Austria
24.
Zurück zum Zitat Palaty C, BC Cancer Agency, Canadian Partnership Against Cancer (2008) Cancer care for all Canadians: improving access and minimizing disparities for vulnerable populations in Canada. BC Cancer Agency, Vancouver Palaty C, BC Cancer Agency, Canadian Partnership Against Cancer (2008) Cancer care for all Canadians: improving access and minimizing disparities for vulnerable populations in Canada. BC Cancer Agency, Vancouver
26.
Zurück zum Zitat Carstairs S, Canada Parliament Senate (2005) Still not there, quality end-of-life care: a progress report. Senate Canada, Ottawa Carstairs S, Canada Parliament Senate (2005) Still not there, quality end-of-life care: a progress report. Senate Canada, Ottawa
31.
Zurück zum Zitat World Health Organization (1996) Cancer pain relief. With a guide to opioid availability. 2nd edn. World Health Organization World Health Organization (1996) Cancer pain relief. With a guide to opioid availability. 2nd edn. World Health Organization
32.
Zurück zum Zitat van den Beuken-van, Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18(9):1437–1449CrossRef van den Beuken-van, Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18(9):1437–1449CrossRef
33.
34.
Zurück zum Zitat United Nations International Narcotics Control Board (2013) Report of the international narcotics control board 2012. United Nations, Vienna United Nations International Narcotics Control Board (2013) Report of the international narcotics control board 2012. United Nations, Vienna
35.
Zurück zum Zitat United Nations International Narcotics Control Board (2015) Report of the international narcotics control board for 2014. United Nations, Vienna United Nations International Narcotics Control Board (2015) Report of the international narcotics control board for 2014. United Nations, Vienna
36.
Zurück zum Zitat United Nations International Narcotics Control Board (2011) Report of the international narcotics control board on the availability of internationally controlled drugs ensuring adequate access for medical and scientific purposes. United Nations, New York United Nations International Narcotics Control Board (2011) Report of the international narcotics control board on the availability of internationally controlled drugs ensuring adequate access for medical and scientific purposes. United Nations, New York
37.
Zurück zum Zitat Anderson KO, Mendoza TR, Payne R, Valero V, Palos GR, Nazario A, Richman SP, Hurley J, Gning I, Lynch GR, Kalish D, Cleeland CS (2004) Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol 22(24):4918–4925. doi:10.1200/JCO.2004.06.115 PubMedCrossRef Anderson KO, Mendoza TR, Payne R, Valero V, Palos GR, Nazario A, Richman SP, Hurley J, Gning I, Lynch GR, Kalish D, Cleeland CS (2004) Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol 22(24):4918–4925. doi:10.​1200/​JCO.​2004.​06.​115 PubMedCrossRef
40.
Zurück zum Zitat Rannestad T, Skjeldestad FE (2012) Socioeconomic conditions and number of pain sites in women. BMC Women’s Health 12 (7) Rannestad T, Skjeldestad FE (2012) Socioeconomic conditions and number of pain sites in women. BMC Women’s Health 12 (7)
41.
Zurück zum Zitat Mosher CE, Duhamel KN, Egert J, Smith MY (2010) Self-efficacy for coping with cancer in a multiethnic sample of breast cancer patients: associations with barriers to pain management and distress. Clin J Pain 26(3):227–234PubMedPubMedCentralCrossRef Mosher CE, Duhamel KN, Egert J, Smith MY (2010) Self-efficacy for coping with cancer in a multiethnic sample of breast cancer patients: associations with barriers to pain management and distress. Clin J Pain 26(3):227–234PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Bell CL, Kuriya M, Fischberg D (2011) Pain outcomes of inpatient pain and palliative care consultations: differences by race and diagnosis. J Palliative Med 14(10):1142–1148. doi:10.1089/jpm.2011.0176 CrossRef Bell CL, Kuriya M, Fischberg D (2011) Pain outcomes of inpatient pain and palliative care consultations: differences by race and diagnosis. J Palliative Med 14(10):1142–1148. doi:10.​1089/​jpm.​2011.​0176 CrossRef
43.
Zurück zum Zitat Castel L, Saville BR, Depuy V, Godley PA, Hartmann KE, Abernethy AP (2008) Racial differences in pain during 1 year among women with metastatic breast cancer: a hazards analysis of interval-censored data. Cancer 112(1):162–170PubMedCrossRef Castel L, Saville BR, Depuy V, Godley PA, Hartmann KE, Abernethy AP (2008) Racial differences in pain during 1 year among women with metastatic breast cancer: a hazards analysis of interval-censored data. Cancer 112(1):162–170PubMedCrossRef
44.
Zurück zum Zitat Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ (1997) Pain and treatment of pain in minority patients with cancer: the Eastern cooperative oncology group minority outpatient pain study. Ann Intern Med 127(9):813–816PubMedCrossRef Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ (1997) Pain and treatment of pain in minority patients with cancer: the Eastern cooperative oncology group minority outpatient pain study. Ann Intern Med 127(9):813–816PubMedCrossRef
45.
Zurück zum Zitat Dhingra L, Lam K, Homel P, Chen J, Chang VT, Zhou J, Chan S, Lam WL, Portenoy R (2011) Pain in underserved community-dwelling Chinese American cancer patients: demographic and medical correlates. Oncologist 16(4):523–533PubMedPubMedCentralCrossRef Dhingra L, Lam K, Homel P, Chen J, Chang VT, Zhou J, Chan S, Lam WL, Portenoy R (2011) Pain in underserved community-dwelling Chinese American cancer patients: demographic and medical correlates. Oncologist 16(4):523–533PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Montague L, Green CR (2009) Cancer and breakthrough pain’s impact on a diverse population. Pain Med 10(3):549–561PubMedCrossRef Montague L, Green CR (2009) Cancer and breakthrough pain’s impact on a diverse population. Pain Med 10(3):549–561PubMedCrossRef
48.
Zurück zum Zitat Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, Lipsitz L, Steel K, Mor V (1998) Management of pain in elderly patients with cancer. J Am Med Assoc 279(23):1877–1882CrossRef Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, Lipsitz L, Steel K, Mor V (1998) Management of pain in elderly patients with cancer. J Am Med Assoc 279(23):1877–1882CrossRef
49.
Zurück zum Zitat Green CR, Montague L, Hart-Johnson TA (2009) Consistent and breakthrough pain in diverse advanced cancer patients: a longitudinal examination. J Pain Symptom Manag 37(5):831–847CrossRef Green CR, Montague L, Hart-Johnson TA (2009) Consistent and breakthrough pain in diverse advanced cancer patients: a longitudinal examination. J Pain Symptom Manag 37(5):831–847CrossRef
50.
Zurück zum Zitat Im E, Chee W, Guevara E, Liu Y, Lim HJ, Tsai HM, Clark M, Bender M, Suk Kim K, Hee Kim Y, Shin H (2007) Gender and ethnic differences in cancer pain experience: a multiethnic survey in the United States. Nurs Res 56(5):296–306PubMedPubMedCentralCrossRef Im E, Chee W, Guevara E, Liu Y, Lim HJ, Tsai HM, Clark M, Bender M, Suk Kim K, Hee Kim Y, Shin H (2007) Gender and ethnic differences in cancer pain experience: a multiethnic survey in the United States. Nurs Res 56(5):296–306PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Miaskowski C (2004) Gender differences in pain, fatigue, and depression in patients with cancer. J Natl Cancer Inst Monogr 32:139–143PubMedCrossRef Miaskowski C (2004) Gender differences in pain, fatigue, and depression in patients with cancer. J Natl Cancer Inst Monogr 32:139–143PubMedCrossRef
53.
Zurück zum Zitat Fink R, Oman KS, Youngwerth J, Bryant LL (2013) A palliative care needs assessment of rural hospitals. J Palliative Med 16(6):638–644CrossRef Fink R, Oman KS, Youngwerth J, Bryant LL (2013) A palliative care needs assessment of rural hospitals. J Palliative Med 16(6):638–644CrossRef
54.
Zurück zum Zitat McGrath P, Holewa H (2012) Reconceptualising relocation for specialist treatment: insights from New Zealand. Support Care Cancer 20(3):499–505PubMedCrossRef McGrath P, Holewa H (2012) Reconceptualising relocation for specialist treatment: insights from New Zealand. Support Care Cancer 20(3):499–505PubMedCrossRef
55.
Zurück zum Zitat Passik S, Whitcomb LA, Kirsh KL, Donaghy K, Theobald D, Holtsclaw E, Edgerton S, Dugan W (2002) A pilot study of oncology staff perceptions of palliative care and psycho-oncology services in rural and community settings in Indiana. J Rural Health 18(1):31–34PubMedCrossRef Passik S, Whitcomb LA, Kirsh KL, Donaghy K, Theobald D, Holtsclaw E, Edgerton S, Dugan W (2002) A pilot study of oncology staff perceptions of palliative care and psycho-oncology services in rural and community settings in Indiana. J Rural Health 18(1):31–34PubMedCrossRef
57.
58.
Zurück zum Zitat Johannsen M, Farver I, Beck N, Zachariae R (2013) The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis. Breast Cancer Res Treat 138(3):675–690. doi:10.1007/s10549-013-2503-4 PubMedCrossRef Johannsen M, Farver I, Beck N, Zachariae R (2013) The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis. Breast Cancer Res Treat 138(3):675–690. doi:10.​1007/​s10549-013-2503-4 PubMedCrossRef
59.
Zurück zum Zitat Koller A, Miaskowski C, De Geest S, Opitz O, Spichiger E (2012) A systematic evaluation of content, structure, and efficacy of interventions to improve patients’ self-management of cancer pain. J Pain Symptom Manag 44(2):264–284. doi:10.1016/j.jpainsymman.2011.08.015 CrossRef Koller A, Miaskowski C, De Geest S, Opitz O, Spichiger E (2012) A systematic evaluation of content, structure, and efficacy of interventions to improve patients’ self-management of cancer pain. J Pain Symptom Manag 44(2):264–284. doi:10.​1016/​j.​jpainsymman.​2011.​08.​015 CrossRef
61.
Zurück zum Zitat Oldenmenger WH, Sillevis Smitt PAE, van Dooren S, Stoter G, van der Rijt CCD (2009) A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal. Eur J Cancer 45(8):1370–1380. doi:10.1016/j.ejca.2009.01.007 PubMedCrossRef Oldenmenger WH, Sillevis Smitt PAE, van Dooren S, Stoter G, van der Rijt CCD (2009) A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal. Eur J Cancer 45(8):1370–1380. doi:10.​1016/​j.​ejca.​2009.​01.​007 PubMedCrossRef
62.
Zurück zum Zitat Gorin SS, Krebs P, Badr H, Janke EA, Jim HSL, Spring B, Mohr DC, Berendsen MA, Jacobsen PB (2012) Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol 30(5):539–547CrossRef Gorin SS, Krebs P, Badr H, Janke EA, Jim HSL, Spring B, Mohr DC, Berendsen MA, Jacobsen PB (2012) Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol 30(5):539–547CrossRef
63.
Zurück zum Zitat Jho HJ, Myung SK, Chang YJ, Kim DH, Ko DH (2013) Efficacy of pain education in cancer patients: a meta-analysis of randomized controlled trials. Support Care Cancer 21(7):1963–1971PubMedCrossRef Jho HJ, Myung SK, Chang YJ, Kim DH, Ko DH (2013) Efficacy of pain education in cancer patients: a meta-analysis of randomized controlled trials. Support Care Cancer 21(7):1963–1971PubMedCrossRef
64.
Zurück zum Zitat O’Connor D, Green SJH (2011) Defining the review question and developing criteria for including studies. In: Higgins J, Green S (eds) Cochrane handbook for systematic reviews of interventions 4.2.6 [updated september 2011]. Wiley, Chichester O’Connor D, Green SJH (2011) Defining the review question and developing criteria for including studies. In: Higgins J, Green S (eds) Cochrane handbook for systematic reviews of interventions 4.2.6 [updated september 2011]. Wiley, Chichester
65.
Zurück zum Zitat Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed
66.
Zurück zum Zitat Watanabe SM, Nekolaichuk CL, Beaumont C (2012) The Edmonton symptom assessment system, a proposed tool for distress screening in cancer patients: development and refinement. Psycho-Oncology 21(9):977–985. doi:10.1002/pon.1996 PubMedCrossRef Watanabe SM, Nekolaichuk CL, Beaumont C (2012) The Edmonton symptom assessment system, a proposed tool for distress screening in cancer patients: development and refinement. Psycho-Oncology 21(9):977–985. doi:10.​1002/​pon.​1996 PubMedCrossRef
67.
Zurück zum Zitat Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap 23(2):129–138PubMed Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap 23(2):129–138PubMed
69.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269PubMedCrossRef Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269PubMedCrossRef
70.
Zurück zum Zitat Armijo-Olivo S, Macedo LG, Gadotti IC, Fuentes J, Stanton T, Magee DJ (2008) Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther 88(2):156–175. doi:10.2522/ptj.20070147 CrossRef Armijo-Olivo S, Macedo LG, Gadotti IC, Fuentes J, Stanton T, Magee DJ (2008) Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther 88(2):156–175. doi:10.​2522/​ptj.​20070147 CrossRef
71.
Zurück zum Zitat Armijo-Olivo S, Fuentes J, Ospina M, Saltaji H, Hartling L (2013) Inconsistency in the items included in tools used in general health research and physical therapy to evaluate the methodological quality of randomized controlled trials: a descriptive analysis. BMC Med Res Methodol: 116. doi:10.1186/1471-2288-13-116 Armijo-Olivo S, Fuentes J, Ospina M, Saltaji H, Hartling L (2013) Inconsistency in the items included in tools used in general health research and physical therapy to evaluate the methodological quality of randomized controlled trials: a descriptive analysis. BMC Med Res Methodol: 116. doi:10.​1186/​1471-2288-13-116
72.
Zurück zum Zitat Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JAC (2011) The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Online) 343 (7829) Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JAC (2011) The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Online) 343 (7829)
73.
Zurück zum Zitat Herbison P, Hay-Smith J, Gillespie WJ (2006) Adjustment of meta-analyses on the basis of quality scores should be abandoned. J Clin Epidemiol 59 (12):1249.e1241-1249.e1211 Herbison P, Hay-Smith J, Gillespie WJ (2006) Adjustment of meta-analyses on the basis of quality scores should be abandoned. J Clin Epidemiol 59 (12):1249.e1241-1249.e1211
74.
Zurück zum Zitat Juni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. J Am Med Assoc 282(11):1054–1060CrossRef Juni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. J Am Med Assoc 282(11):1054–1060CrossRef
75.
Zurück zum Zitat Da Costa BR, Hilfiker R, Egger M (2013) PEDro’s bias: summary quality scores should not be used in meta-analysis. J Clin Epidemiol 66(1):75–77PubMedCrossRef Da Costa BR, Hilfiker R, Egger M (2013) PEDro’s bias: summary quality scores should not be used in meta-analysis. J Clin Epidemiol 66(1):75–77PubMedCrossRef
76.
Zurück zum Zitat Higgins J, Altman D (2008) Chapter 8: assessing risk of bias in included studies. In: Higgins J, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.0. Wiley, ChichesterCrossRef Higgins J, Altman D (2008) Chapter 8: assessing risk of bias in included studies. In: Higgins J, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.0. Wiley, ChichesterCrossRef
77.
Zurück zum Zitat Higgins JPT, Altman DG, Goetzsche PC, Juni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JAC (2011) The cochrane collaboration’s tool for assessing risk of bias in randomized trials. BMJ 343 (7829) Higgins JPT, Altman DG, Goetzsche PC, Juni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JAC (2011) The cochrane collaboration’s tool for assessing risk of bias in randomized trials. BMJ 343 (7829)
78.
Zurück zum Zitat Furlan AD, Pennick V, Bombardier C, Van Tulder M (2009) 2009 Updated method guidelines for systematic reviews in the Cochrane back review group. Spine 34(18):1929–1941PubMedCrossRef Furlan AD, Pennick V, Bombardier C, Van Tulder M (2009) 2009 Updated method guidelines for systematic reviews in the Cochrane back review group. Spine 34(18):1929–1941PubMedCrossRef
79.
Zurück zum Zitat Hartling L, Hamm MP, Milne A, Vandermeer B, Santaguida PL, Ansari M, Tsertsvadze A, Hempel S, Shekelle P, Dryden DM (2012) Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. J Clin Epidemiol 66(9):973–981PubMedCrossRef Hartling L, Hamm MP, Milne A, Vandermeer B, Santaguida PL, Ansari M, Tsertsvadze A, Hempel S, Shekelle P, Dryden DM (2012) Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. J Clin Epidemiol 66(9):973–981PubMedCrossRef
80.
Zurück zum Zitat Hartling L, Bond K, Vandermeer B, Seida J, Dryden D, Rowe B (2011) Applying the risk of bias tool in a systematic review of combination longacting betaagonists and inhaled corticosteroids for persistent asthma. PLoS Med 6 (2) Hartling L, Bond K, Vandermeer B, Seida J, Dryden D, Rowe B (2011) Applying the risk of bias tool in a systematic review of combination longacting betaagonists and inhaled corticosteroids for persistent asthma. PLoS Med 6 (2)
81.
Zurück zum Zitat Deeks J, Higgins J, Altman D (2008) Chapter 9: analysing data and undertaking meta-analyses. In: Higgins J, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.0.0 [updated February 2008]. . version 5.0 edn. Available from www.cochrane-handbook.org, 2008 Deeks J, Higgins J, Altman D (2008) Chapter 9: analysing data and undertaking meta-analyses. In: Higgins J, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.0.0 [updated February 2008]. . version 5.0 edn. Available from www.​cochrane-handbook.​org, 2008
82.
Zurück zum Zitat Berard A, Bravo G (1998) Combining studies using effect sizes and quality scores: application to bone loss in postmenopausal women. J Clin Epidemiol 51(10):801–807PubMedCrossRef Berard A, Bravo G (1998) Combining studies using effect sizes and quality scores: application to bone loss in postmenopausal women. J Clin Epidemiol 51(10):801–807PubMedCrossRef
84.
Zurück zum Zitat Changrani J, Lieberman M, Golant M, Rios P, Damman J, Gany F (2008) Online cancer support groups: experiences with underserved immigrant Latinas. Prim Psychiatry 15(10):55–62 Changrani J, Lieberman M, Golant M, Rios P, Damman J, Gany F (2008) Online cancer support groups: experiences with underserved immigrant Latinas. Prim Psychiatry 15(10):55–62
85.
Zurück zum Zitat Fuentes J, Armijo-Olivo S, Funabashi M, Miciak M, Dick B, Warren S, Rashiq S, Magee DJ, Gross DP (2014) Enhanced therapeutic alliance modulates pain intensity and muscle pain sensitivity in patients with chronic low back pain: an experimental controlled study. Phys Ther 94(4):477–489PubMedCrossRef Fuentes J, Armijo-Olivo S, Funabashi M, Miciak M, Dick B, Warren S, Rashiq S, Magee DJ, Gross DP (2014) Enhanced therapeutic alliance modulates pain intensity and muscle pain sensitivity in patients with chronic low back pain: an experimental controlled study. Phys Ther 94(4):477–489PubMedCrossRef
86.
Zurück zum Zitat Green E, Zwaal C, Beals C, Fitzgerald B, Harle I, Jones J, Tsui J, Volpe J, Yoshimoto D, Wiernikowski J (2010) Cancer-related pain management: a report of evidence-based recommendations to guide practice. Clin J Pain 26(6):449–462PubMedCrossRef Green E, Zwaal C, Beals C, Fitzgerald B, Harle I, Jones J, Tsui J, Volpe J, Yoshimoto D, Wiernikowski J (2010) Cancer-related pain management: a report of evidence-based recommendations to guide practice. Clin J Pain 26(6):449–462PubMedCrossRef
87.
88.
Zurück zum Zitat Huang HY, Ezenwa MO, Wilkie DJ, Judge MK (2013) ResearchTracking: monitoring gender and ethnic minority recruitment and retention in cancer symptom studies. Cancer Nurs 36(3):E1–E6PubMedPubMedCentralCrossRef Huang HY, Ezenwa MO, Wilkie DJ, Judge MK (2013) ResearchTracking: monitoring gender and ethnic minority recruitment and retention in cancer symptom studies. Cancer Nurs 36(3):E1–E6PubMedPubMedCentralCrossRef
Metadaten
Titel
Non-pharmacological cancer pain interventions in populations with social disparities: a systematic review and meta-analysis
verfasst von
Anna Santos Salas
Jorge Fuentes Contreras
Susan Armijo-Olivo
Humam Saltaji
Sharon Watanabe
Thane Chambers
Lori Walter
Greta G. Cummings
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2998-9

Weitere Artikel der Ausgabe 2/2016

Supportive Care in Cancer 2/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.